These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3791354)

  • 1. Antiarrhythmic and haemodynamic effects of tiapamil, a new calcium antagonist, during coronary artery occlusion and reperfusion in dogs.
    Shargorodsky BM; Braun S; Belhassen B; Laniado S
    Cardiovasc Res; 1986 Sep; 20(9):652-7. PubMed ID: 3791354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of tiapamil against ventricular fibrillation during coronary artery occlusion.
    Raeder EA; Verrier RL; Lown B
    Am Heart J; 1986 May; 111(5):878-82. PubMed ID: 3706107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Comparative effects on left ventricular function.
    Muller CA; Opie LH; Hamm CW; Peisach M; Pineda CA; Thandroyen FT
    Circulation; 1988 Jul; 78(1):227-32. PubMed ID: 3383406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tiapamil on myocardial performance in coronary artery disease.
    Braun S; Miller H; Terdiman R; Laniado S
    Cardiology; 1982; 69 Suppl():79-84. PubMed ID: 7151086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effects of tiapamil on exercise-induced arrhythmias in patients with coronary artery disease.
    Burkart F; Baitsch G; Braun S; Bertel O; Cocco G
    Cardiology; 1982; 69 Suppl():165-71. PubMed ID: 6758932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.
    Gerold M; Eigenmann R; Haeusler G
    J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effect of the calcium antagonist tiapamil (Ro 11-1781) by intravenous administration in patients with coronary heart disease.
    Nowak FG; Cocco G; Chu D; Gasser DF
    Clin Cardiol; 1980 Dec; 3(6):371-6. PubMed ID: 6161729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
    Saini RK; Fulmor IE; Antonaccio MJ
    J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute antianginal effect of tiapamil.
    Gasic S
    Cardiology; 1982; 69 Suppl():209-24. PubMed ID: 6758933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiapamil in the treatment of lidocaine-resistant ventricular arrhythmias complicating acute myocardial infarction.
    Lessem J
    Cardiology; 1982; 69 Suppl():199-208. PubMed ID: 7151080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiapamil--a new calcium antagonist.
    Opie LH; Muller CA; Thandroyen FT; Lloyd EA; Mabin T; Commerford PJ; Eichler HG
    S Afr Med J; 1985 Jun; 67(22):881-3. PubMed ID: 3890216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cardiac arrhythmias with tiapamil.
    Brisse B; Bender F; Bramann H; Kuhs H; Schwippe G
    Cardiology; 1982; 69 Suppl():144-8. PubMed ID: 7151076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiapamil, a new calcium antagonist: hemodynamic effects in patients with acute myocardial infarction.
    Eichler HG; Mabin TA; Commerford PJ; Lloyd EA; Beck W; Opie LH
    Circulation; 1985 Apr; 71(4):779-86. PubMed ID: 3882269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection by the calcium antagonist tiapamil, against cardiac lymphatic enzyme leakage and arrhythmias in canine hearts during reperfusion.
    Matsuura A; Ishihara T; Nakamura K; Himori N; Nakamura K
    J Cardiovasc Pharmacol; 1986; 8(1):90-8. PubMed ID: 2419700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic effects of intravenous tiapamil in patients with coronary artery disease.
    Bopp P; Mérier G; Scheidegger D; Gabathuler J; Rutishauser W
    Cardiology; 1982; 69 Suppl():91-8. PubMed ID: 7151088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs.
    Saini RK; Fulmor IE; Parham CS; Antonaccio MJ
    J Pharmacol Exp Ther; 1986 Apr; 237(1):1-8. PubMed ID: 3958960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral tiapamil treatment of arrhythmias in cardiac patients.
    Menzel T; Kirchner P
    Cardiology; 1982; 69 Suppl():192-8. PubMed ID: 6185224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic effect of tiapamil in patients with acute myocardial infarction.
    Dubner S; Gimeno G; Elencwajg B; Quinteiro R; Tronge J; Bertolasi C
    Cardiology; 1982; 69 Suppl():172-80. PubMed ID: 7151078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs.
    Saini RK; Antonaccio MJ
    J Pharmacol Exp Ther; 1982 Apr; 221(1):29-36. PubMed ID: 7062289
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic effects of tiapamil and verapamil in conscious rats following chronic myocardial infarction.
    Clozel JP
    Cardiology; 1988; 75(3):161-9. PubMed ID: 3416326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.